Psilocybin Treatments
Debate between Karin Smyth and Crispin Blunt(1 year, 7 months ago)
Commons ChamberRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Karin Smyth (Bristol South) (Lab)
It is a pleasure to see you in the Chair, Madam Deputy Speaker. I thank my hon. Friend the Member for Warrington North (Charlotte Nichols) and the hon. Members for Reigate (Crispin Blunt) and for Inverclyde (Ronnie Cowan) for their incredibly moving and well-informed speeches, and the Backbench Business Committee for supporting their application. I recognise the work that they have done for many years on this subject. As we know, in this place many Members take up individual causes that often do not get the numbers and publicity that they might warrant, but we are dogged in continuing to do that. I managed to avoid the comments that the Minister had about whether he was the appropriate person or not. I say simply that I am here on behalf of the Labour party. I am pleased to be here, I serve, it is beyond my paygrade as to who or why someone is here, but I am pleased to be here.
Like the hon. Member for West Dunbartonshire (Martin Docherty-Hughes) I too needed to appraise myself of the details of this subject, and that is one advantage of being able to speak from the health team. For more than 50 years we have been investigating these drugs as potential treatments for a number of neurological and psychiatric conditions including, as we have heard, depression. There is now another wave of research into these drugs and the treatment of neuropsychiatric disorders such as treatment-resistant depression, anorexia and PTSD, and we have heard about that strongly today. Our priority is to improve treatment and prevention services and, in particular, to support research.
The point has been well made that this subject falls between Departments—Health and the Home Office—as is the case on many subjects. Wherever it falls, it is all of our responsibility, because at the heart of this, as we have heard strongly, is the needs of people—our constituents—for treatment of these conditions. As the motion says, we need evidence-led and data-driven interventions. That is why the last Labour Government established the National Institute for Health and Care Excellence to balance care with value for money, to deliver for individuals and society. That involved rigorous and independent assessment of complex evidence. That is why, for the use of psilocybin and other treatments in the NHS, I strongly support an evidence-based approach and those processes.
This discussion highlights the opportunities available to us and to our constituents through a vibrant life sciences industry. Labour is committed to supporting our health sciences industry to improve the health and wealth of our country. That is why I am proud and hugely supportive of our fantastic academic and clinical colleagues in the NHS and UK higher institutions. They are doing world-leading research through the use of both experimental and gold-standard clinical trials to look at whether such treatments, among others, are helpful for those with severe and enduring mental health conditions. That includes interesting work on the use of psilocybin alongside talking therapies.
We hear much from the Government about their commitment to research and development, but it would be helpful to hear from the Minister about what pragmatic support the Government are giving to the research sector, universities and pharmaceutical companies to enable more research into this area.
It is clear that that work cannot sit in a silo. Following the Adjournment debate on this topic, which was responded to by the Minister for Crime, Policing and Fire, the right hon. Member for Croydon South (Chris Philp), I would like to know what conversations the Minister has had with counterparts in the Home Office regarding the controlled drugs licensing regime to support research and clinical trials in the UK. Additionally, will he update the House on part 2 of the Advisory Council on the Misuse of Drugs’ advice, which was commissioned in December? That would be helpful. This is a cross-cutting issue, so he may have had conversations with Health colleagues on it, but I understand that it falls under his Department. Members on both sides of the House have come here today with good will to work cross-party—we have seen that in evidence this afternoon—and it is crucial that the Minister echoes that sentiment and outlines how the Departments are working collaboratively on this matter.
We cannot ignore the lack of a wider Government strategy on mental health, particularly in Mental Health Awareness Week. For far too long the Government have been dragging their heels on mental health. Last year they lauded themselves for putting together a 10-year Government mental health plan. However, like so much that comes from them at the moment, after months of consultations, pages of evidence and vital input from the public and experts, again we have more backsliding on those commitments. The Government must stop pushing things into the long grass and get serious about mental health.
The long-awaited reform of the Mental Health Act 1983 is a much-needed step in the right direction on improving people’s experiences with mental health services, but, despite the Joint Committee publishing its report on the draft Bill, there is still little progress. If we want to see patients having greater control over treatment options and accessing care tailored to their needs, the Government must get more serious about mental health services.
More than 7 million people are waiting for NHS treatment, and they are waiting longer than ever before, in pain and discomfort. The NHS went into the pandemic with record waiting lists and 100,000 vacancies, and there are more than 1.6 million people awaiting mental health treatment alone. Adults are waiting 5.4 million hours in A&E while we are experiencing a mental health crisis. We have heard about some of those crises today, and that is not the place for treatment. Without a proper plan for prevention and early intervention, and without a suitable workforce plan, patients will continue to be left behind.
Even where patients do get a referral, the appropriate course of action for their specific treatment needs is often not available. That accessibility to tailored mental health support goes to the core of why we are here. Across the NHS, there are frequently supply issues with antidepressants—medication that is already licensed—that people are dependent upon. Without secure supply chains, how can patients be secure in the knowledge that they will continue to receive their prescribed treatment? The anxiety that disruptions to treatment can cause patients cannot be ignored. That is why it is crucial that Ministers understand the importance of a variety of treatment options and of research and development. If the Minister could give an update on those supply issues and the assessment of stock availability, that will be welcomed by the people watching this debate.
The Government need to get a grip on mental health services. If they do not, we will. We will put prevention and early intervention at the forefront of our approach to mental health. We will place a mental health specialist in every school and an open access hub for young people in every community. We will double the number of district nurses qualifying every year and create additional nursing and midwifery placements in the health service. We will double the number of medical places so that we have the doctors that our NHS needs. We will guarantee mental health treatment within a month by recruiting an extra 8,500 mental health staff. We will reform the NHS to shift its focus to early diagnosis and intervention, as well as preventing ill health in the first place. Working with leading figures from research, life sciences and patient care will be a huge part of that.
